Showcases Stock ranks Forex

Amarin Corp Ads (AMRN)
4.6  0 (0%) 11-27 13:00
Open: 4.6 Pre. Close: 4.6
High: 4.67 Low: 4.54
Volume: 4,224,097 Market Cap: 1,789M
Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 4.686 - 4.703 4.703 - 4.717
Low: 4.414 - 4.436 4.436 - 4.453
Close: 4.567 - 4.601 4.601 - 4.628
Stock Technical Analysis
Target: Six months: 6.06
One year: 7.08
Support: Support1: 4.43
Support2: 3.96
Resistance: Resistance1: 5.19
Resistance2: 6.06
Pivot: 4.39
Moving Averages: MA(5): 4.55
MA(20): 4.51
MA(100): 5.43
MA(250): 9.92
MACD: MACD(12,26): -0.06
Signal(12,26,9): -0.10
%K %D: %K(14,3): 54.73
%D(3): 49.41
RSI: RSI(14): 50.44
52-Week: High: 26.12
Low: 3.36
Change(%): -78.5
Average Vol(K): 3-Month: 837361
10-Days: 975446
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

AMRN has closed below upper band by 24.8%. Bollinger Bands are 45% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMRN's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Thu, 05 Nov 2020
Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire

Mon, 05 Oct 2020
ROCE Insights For Amarin Corp - Yahoo Finance

Fri, 11 Sep 2020
Amarin (AMRN): Vascepa’s International Opportunity Remains Intact, Says Analyst - Yahoo Finance

Wed, 09 Sep 2020
Amarin: 'The Future Ain't What It Used To Be' - Seeking Alpha

Thu, 03 Sep 2020
Amarin (AMRN) Bears the Brunt of a Price Target Cut - Yahoo Finance

Tue, 01 Sep 2020
Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock? - Yahoo Finance

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 388.83
Shares Float (M) 346.96
% Held by Insiders 1.03
% Held by Institutions 42.69
Shares Short (K) 23780
Shares Short Prior Month (K) 24860
Stock Financials
EPS -0.044
Book Value (p.s.) 1.550
Profit Margin -2.69
Operating Margin -3.61
Return on Assets (ttm) -1.5
Return on Equity (ttm) -2.6
Qtrly Rev. Growth 39.2
Gross Profit (p.s.) 0.858
Sales Per Share 1.518
EBITDA (p.s.) -0.050
Qtrly Earnings Growth
Operating Cash Flow (M) 7.64
Levered Free Cash Flow (M) 14.15
Stock Valuation
PE Ratio -104.55
PEG Ratio
Price to Book value 2.97
Price to Sales 3.03
Price to Cash Flow 234.11
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator